Christophe Passot

692 total citations
28 papers, 514 citations indexed

About

Christophe Passot is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology. According to data from OpenAlex, Christophe Passot has authored 28 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Oncology and 9 papers in Immunology. Recurrent topics in Christophe Passot's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Inflammatory Bowel Disease (4 papers). Christophe Passot is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Inflammatory Bowel Disease (4 papers). Christophe Passot collaborates with scholars based in France, United States and Belgium. Christophe Passot's co-authors include Gilles Paintaud, David Ternant, Denis Mulleman, Théodora Bejan‐Angoulvant, Valérie Gouilleux‐Gruart, Céline Desvignes, Hervé Watier, Christophe Arnoult, Nadine Baroukh and Thierry Lecomte and has published in prestigious journals such as The Journal of Immunology, Annals of Oncology and The Journal of Pediatrics.

In The Last Decade

Christophe Passot

27 papers receiving 510 citations

Peers

Christophe Passot
Joyce Hui‐Yuen United States
Peter Noertersheuser United States
Alejandro Villalba Spain
Masako Otani Japan
Devesh Mewar United Kingdom
Dan Birmingham United States
Petra Roll Germany
László Váróczy Hungary
Alexandros Papachristofilou Switzerland
Obbo W Bredewold Netherlands
Joyce Hui‐Yuen United States
Christophe Passot
Citations per year, relative to Christophe Passot Christophe Passot (= 1×) peers Joyce Hui‐Yuen

Countries citing papers authored by Christophe Passot

Since Specialization
Citations

This map shows the geographic impact of Christophe Passot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Passot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Passot more than expected).

Fields of papers citing papers by Christophe Passot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Passot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Passot. The network helps show where Christophe Passot may publish in the future.

Co-authorship network of co-authors of Christophe Passot

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Passot. A scholar is included among the top collaborators of Christophe Passot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Passot. Christophe Passot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Campone, Mario, Véronique Verrièle, Jean-Marie Marion, et al.. (2024). Learning to Train and to Explain a Deep Survival Model with Large-Scale Ovarian Cancer Transcriptomic Data. Biomedicines. 12(12). 2881–2881.
2.
Dumont, Frédéric, Vahan Képénékian, Christophe Passot, et al.. (2024). PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial. European Journal of Surgical Oncology. 50(9). 108468–108468. 2 indexed citations
3.
Gatault, Philippe, Rébecca Sberro‐Soussan, Christophe Passot, et al.. (2024). Eculizumab dose tapering should take into account the nonlinearity of its pharmacokinetics. British Journal of Clinical Pharmacology. 90(5). 1312–1321. 1 indexed citations
4.
Rioux‐Leclercq, Nathalie, Maxime Meylan, Christophe Passot, et al.. (2023). Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 11(11). e006885–e006885. 8 indexed citations
5.
Paintaud, Gilles, Nicolas Azzopardi, Christophe Passot, et al.. (2023). Relationship Between Cetuximab Target-Mediated Pharmacokinetics and Progression-Free Survival in Metastatic Colorectal Cancer Patients. Clinical Pharmacokinetics. 62(9). 1263–1274. 1 indexed citations
6.
Ternant, David, Marc Pfister, Denis Mulleman, et al.. (2021). Infliximab Treatment Does Not Lead to Full TNF-α Inhibition: A Target-Mediated Drug Disposition Model. Clinical Pharmacokinetics. 61(1). 143–154. 7 indexed citations
7.
Augereau, Paule, et al.. (2021). Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genes. Genome Medicine. 13(1). 174–174. 4 indexed citations
8.
9.
10.
Bonneau, Claire, Gilles Paintaud, Olivier Trédan, et al.. (2018). Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis. European Journal of Cancer. 95. 75–84. 66 indexed citations
11.
Lioger, Bertrand, F. Maillot, David Ternant, et al.. (2018). Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials. The Journal of Pediatrics. 204. 225–233.e8. 8 indexed citations
12.
Desvignes, Céline, Christophe Passot, David Ternant, et al.. (2018). Development and Validation of an ELISA to Study Panitumumab Pharmacokinetics. Bioanalysis. 10(4). 205–214. 4 indexed citations
13.
Ternant, David, Christophe Passot, Alexandre Aubourg, et al.. (2017). Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration. Clinical Pharmacokinetics. 57(9). 1173–1184. 15 indexed citations
14.
Passot, Christophe, Céline Desvignes, David Ternant, et al.. (2017). Development and Validation of an Enzyme-Linked Immunosorbent Assay to Measure Free Eculizumab Concentration in Serum. Bioanalysis. 9(16). 1227–1235. 10 indexed citations
15.
Arnoult, Christophe, Guillaume Brachet, Nicolas Azzopardi, et al.. (2017). Crucial Role for Immune Complexes but Not FcRn in Immunization against Anti–TNF-α Antibodies after a Single Injection in Mice. The Journal of Immunology. 199(2). 418–424. 18 indexed citations
16.
Ternant, David, Théodora Bejan‐Angoulvant, Christophe Passot, Denis Mulleman, & Gilles Paintaud. (2015). Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis. Clinical Pharmacokinetics. 54(11). 1107–1123. 84 indexed citations
17.
Passot, Christophe, Christophe Arnoult, Élodie Beaumont, et al.. (2015). The neonatal Fc receptor does not modulate hepatitis C virus neutralization. Journal of General Virology. 96(5). 1062–1066. 4 indexed citations
18.
Passot, Christophe, Nicolas Azzopardi, Sylvaine Renault, et al.. (2013). Influence ofFCGRTgene polymorphisms on pharmacokinetics of therapeutic antibodies. mAbs. 5(4). 614–619. 56 indexed citations
19.
Désoubeaux, Guillaume, Charline Caumont, Christophe Passot, et al.. (2011). Two cases of opportunistic parasite infections in patients receiving alemtuzumab. Journal of Clinical Pathology. 65(1). 92–95. 9 indexed citations
20.
Barbut, Frédéric, et al.. (2007). Efficacy of 2 Alcohol-Based Gels and 1 Alcohol-Based Rinse for Surgical Hand Disinfection. Infection Control and Hospital Epidemiology. 28(8). 1013–1015. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joyce Hui‐Yuen Breakdown of academic impact, for papers by Peter Noertersheuser Breakdown of academic impact, for papers by Alejandro Villalba Breakdown of academic impact, for papers by Masako Otani Breakdown of academic impact, for papers by Devesh Mewar Breakdown of academic impact, for papers by Dan Birmingham Breakdown of academic impact, for papers by Petra Roll Breakdown of academic impact, for papers by László Váróczy Breakdown of academic impact, for papers by Alexandros Papachristofilou Breakdown of academic impact, for papers by Obbo W Bredewold
Rankless by CCL
2026